Chemoinformaics analysis of 3-Ethyl-4-methyl-1H-pyrrole-2,5-dione
| Molecular Weight | 139.154 | nRot | 1 |
| Heavy Atom Molecular Weight | 130.082 | nRig | 2 |
| Exact Molecular Weight | 139.063 | nRing | 1 |
| Solubility: LogS | -5.439 | nHRing | 1 |
| Solubility: LogP | 7.298 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 19 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 9 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 7 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 20.3951 |
| nHD | 1 | BPOL | 11.3349 |
| QED | 0.291 |
| Synth | 2.144 |
| Natural Product Likeliness | 1.051 |
| NR-PPAR-gamma | 0.969 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0 |
| HIA | 0.009 |
| CACO-2 | -4.862 |
| MDCK | 0.0000222 |
| BBB | 0.119 |
| PPB | 0.988299 |
| VDSS | 0.643 |
| FU | 0.0117434 |
| CYP1A2-inh | 0.32 |
| CYP1A2-sub | 0.17 |
| CYP2c19-inh | 0.236 |
| CYP2c19-sub | 0.065 |
| CYP2c9-inh | 0.245 |
| CYP2c9-sub | 0.988 |
| CYP2d6-inh | 0.004 |
| CYP2d6-sub | 0.051 |
| CYP3a4-inh | 0.053 |
| CYP3a4-sub | 0.016 |
| CL | 2.796 |
| T12 | 0.493 |
| hERG | 0.03 |
| Ames | 0.005 |
| ROA | 0.013 |
| SkinSen | 0.949 |
| Carcinogencity | 0.103 |
| EI | 0.986 |
| Respiratory | 0.708 |
| NR-Aromatase | 0.318 |
| Antiviral | No |
| Prediction | 0.921191 |